High-risk acute myeloid leukemia (AML) frequently exhibits increased expression of the transcription factor MDS1 and EVI1 complex locus protein (MECOM), which is essential for hematopoietic stem cells in healthy states. Here, MECOM is linked to acute myeloid leukemia.